{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T03:35:10Z","timestamp":1785900910959,"version":"3.56.0"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T00:00:00Z","timestamp":1745366400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.biopha.2025.118086","type":"journal-article","created":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T23:42:35Z","timestamp":1745883755000},"page":"118086","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Febuxostat alleviate metabolic dysfunction-associated steatohepatitis in rat model via targeting inflammation, cell death, and intestinal barrier dysfunction"],"prefix":"10.1016","volume":"187","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6852-3954","authenticated-orcid":false,"given":"Marwa","family":"Matboli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maha","family":"Saad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manar Fouad","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amany","family":"Helmy Hasanin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghada M.","family":"Ellithy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marian Samir","family":"Abdelwahab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eman Hamdy Badr","family":"Eltantawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghada Galal","family":"Hamam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amany E.","family":"Hamoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwa M.","family":"El-Shafei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nehal","family":"samir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"17","key":"10.1016\/j.biopha.2025.118086_bib1","doi-asserted-by":"crossref","first-page":"10148","DOI":"10.3390\/ijms231710148","article-title":"Rosavin ameliorates hepatic inflammation and fibrosis in the nash rat model via targeting hepatic cell death","volume":"23","author":"Albadawy","year":"2022","journal-title":"Int J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2025.118086_bib2","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgast-2021-000780","article-title":"Prevalence of and risk factors for non-alcoholic fatty liver disease (NAFLD) and fibrosis among young adults in Egypt","volume":"8","author":"Tomah","year":"2021","journal-title":"BMJ Open Gastroenterol."},{"key":"10.1016\/j.biopha.2025.118086_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111781","article-title":"Probiotic-prebiotic-synbiotic modulation of (YAP1, LATS1 and NF2 mRNAs\/miR-1205\/lncRNA SRD5A3-AS1) panel in NASH animal model","volume":"140","author":"Gadallah","year":"2021","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.biopha.2025.118086_bib4","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.jhep.2014.12.012","article-title":"NAFLD: A multisystem disease","volume":"62","author":"Byrne","year":"2015","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.biopha.2025.118086_bib5","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/s41575-019-0210-2","article-title":"Adaptive immunity: an emerging player in the progression of NAFLD","volume":"17","author":"Sutti","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.biopha.2025.118086_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115656","article-title":"Molecular mechanism and potential therapeutic targets of necroptosis and ferroptosis in Alzheimer\u2019s disease","volume":"168","author":"Chavoshinezhad","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"14","key":"10.1016\/j.biopha.2025.118086_bib7","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.3748\/wjg.v30.i14.1968","article-title":"Necroptosis contributes to non-alcoholic fatty liver disease pathoetiology with promising diagnostic and therapeutic functions","volume":"30","author":"Sun","year":"2024","journal-title":"World J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118086_bib8","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1146\/annurev-cellbio-100616-060600","article-title":"Structures, Functions, and Dynamics of ESCRT-III\/Vps4 Membrane Remodeling and Fission Complexes","volume":"34","author":"McCullough","year":"2018","journal-title":"Annu Rev. Cell Dev. Biol."},{"key":"10.1016\/j.biopha.2025.118086_bib9","article-title":"Insights into the function of ESCRT and its role in enveloped virus infection","volume":"14","author":"Wang","year":"2023","journal-title":"Front Microbiol"},{"issue":"2","key":"10.1016\/j.biopha.2025.118086_bib10","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.cell.2017.03.020","article-title":"ESCRT-III Acts Downstream of MLKL to regulate necroptotic cell death and its consequences","volume":"169","author":"Gong","year":"2017","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.biopha.2025.118086_bib11","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1080\/15548627.2024.2395134","article-title":"USP8 promotes intracellular infection by enhancing ESCRT-mediated membrane repair, limiting xenophagy, and reducing oxidative stress","volume":"21","author":"Chandra","year":"2025","journal-title":"Autophagy"},{"issue":"3","key":"10.1016\/j.biopha.2025.118086_bib12","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/s41556-023-01098-9","article-title":"STING signalling is terminated through ESCRT-dependent microautophagy of vesicles originating from recycling endosomes","volume":"25","author":"Kuchitsu","year":"2023","journal-title":"Nat. Cell Biol."},{"issue":"6","key":"10.1016\/j.biopha.2025.118086_bib13","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1038\/emboj.2010.6","article-title":"VHS domains of ESCRT-0 cooperate in high-avidity binding to polyubiquitinated cargo","volume":"29","author":"Ren","year":"2010","journal-title":"EMBO J."},{"key":"10.1016\/j.biopha.2025.118086_bib14","article-title":"The endosomal sorting complex required for transport repairs the membrane to delay cell death","volume":"12","author":"Yang","year":"2022","journal-title":"Front Oncol."},{"issue":"3","key":"10.1016\/j.biopha.2025.118086_bib15","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.ajhg.2024.02.005","article-title":"Bi-allelic variants in SNF8 cause a disease spectrum ranging from severe developmental and epileptic encephalopathy to syndromic optic atrophy","volume":"111","author":"Brugger","year":"2024","journal-title":"Am. J. Hum. Genet."},{"issue":"10","key":"10.1016\/j.biopha.2025.118086_bib16","article-title":"Risk factors associated with intestinal permeability in an adult population: A systematic review","volume":"73","author":"Leech","year":"2019","journal-title":"Int J. Clin. Pr."},{"issue":"6","key":"10.1016\/j.biopha.2025.118086_bib17","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1002\/hep.22848","article-title":"Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease","volume":"49","author":"Miele","year":"2009","journal-title":"Hepatology"},{"issue":"19","key":"10.1016\/j.biopha.2025.118086_bib18","doi-asserted-by":"crossref","first-page":"11689","DOI":"10.3390\/ijms231911689","article-title":"Current Research on the Pathogenesis of NAFLD\/NASH and the Gut\u2013Liver Axis: Gut Microbiota, Dysbiosis, and Leaky-Gut Syndrome","volume":"23","author":"Kobayashi","year":"2022","journal-title":"Int J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2025.118086_bib19","doi-asserted-by":"crossref","first-page":"G42","DOI":"10.1152\/ajpgi.00443.2014","article-title":"The xanthine oxidase inhibitor febuxostat suppresses development of nonalcoholic steatohepatitis in a rodent model","volume":"309","author":"Nakatsu","year":"2015","journal-title":"Am. J. Physiol. -Gastrointest. Liver Physiol."},{"key":"10.1016\/j.biopha.2025.118086_bib20","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.12659\/MSM.899852","article-title":"Hyperuricemia-Related Diseases and Xanthine Oxidoreductase (XOR) Inhibitors: An Overview","volume":"22","author":"Chen","year":"2016","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.biopha.2025.118086_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2019\/7591840","article-title":"Resveratrol Attenuates Oxidative Stress-Induced Intestinal Barrier Injury through PI3K\/Akt-Mediated Nrf2 Signaling Pathway","volume":"2019","author":"Zhuang","year":"2019","journal-title":"Oxid. Med Cell Longev."},{"issue":"4","key":"10.1016\/j.biopha.2025.118086_bib22","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.jhep.2018.05.036","article-title":"Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016\u20132030","volume":"69","author":"Estes","year":"2018","journal-title":"J. Hepatol."},{"issue":"20","key":"10.1016\/j.biopha.2025.118086_bib23","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1042\/CS20210405","article-title":"Xanthine oxidase inhibitor febuxostat reduces atrial fibrillation susceptibility by inhibition of oxidized CaMKII in Dahl salt-sensitive rats","volume":"135","author":"Xu","year":"2021","journal-title":"Clin. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2025.118086_bib24","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/nar\/30.1.207","article-title":"Gene expression omnibus: NCBI gene expression and hybridization array data repository","volume":"30","author":"Edgar","year":"2002","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"10.1016\/j.biopha.2025.118086_bib25","doi-asserted-by":"crossref","first-page":"G42","DOI":"10.1152\/ajpgi.00443.2014","article-title":"The xanthine oxidase inhibitor febuxostat suppresses development of nonalcoholic steatohepatitis in a rodent model","volume":"309","author":"Nakatsu","year":"2015","journal-title":"Am. J. Physiol. -Gastrointest. Liver Physiol."},{"issue":"8","key":"10.1016\/j.biopha.2025.118086_bib26","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1007\/s00210-016-1239-1","article-title":"Febuxostat, a novel xanthine oxidoreductase inhibitor, improves hypertension and endothelial dysfunction in spontaneously hypertensive rats","volume":"389","author":"Shirakura","year":"2016","journal-title":"Naunyn Schmiede Arch. Pharm."},{"key":"10.1016\/j.biopha.2025.118086_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2017\/2739539","article-title":"Febuxostat attenuates renal damage besides exerting hypouricemic effect in streptozotocin-induced diabetic rats","volume":"2017","author":"Ran","year":"2017","journal-title":"Int J. Nephrol."},{"key":"10.1016\/j.biopha.2025.118086_bib28","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ejphar.2017.02.046","article-title":"Ameliorative effects of sildenafil and\/or febuxostat on doxorubicin-induced nephrotoxicity in rats","volume":"805","author":"Khames","year":"2017","journal-title":"Eur. J. Pharm."},{"issue":"02","key":"10.1016\/j.biopha.2025.118086_bib29","doi-asserted-by":"crossref","first-page":"115","DOI":"10.5414\/CP202394","article-title":"Pharmacokinetics and tolerability of febuxostat after oral administration in healthy Chinese volunteers: a randomized, open-label, singleand multiple-dose three-way crossover study","volume":"54","author":"Zhou","year":"2016","journal-title":"Int. J. Clin. Pharmacol. Ther."},{"issue":"9","key":"10.1016\/j.biopha.2025.118086_bib30","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.3348\/kjr.2019.0068","article-title":"Quantitative Evaluation of Hepatic Steatosis Using Normalized Local Variance in a Rat Model: Comparison with Histopathology as the Reference Standard","volume":"20","author":"Bae","year":"2019","journal-title":"Korean J. Radio."},{"issue":"9","key":"10.1016\/j.biopha.2025.118086_bib31","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.3348\/kjr.2019.0068","article-title":"Quantitative evaluation of hepatic steatosis using normalized local variance in a rat model: comparison with histopathology as the reference standard","volume":"20","author":"Bae","year":"2019","journal-title":"Korean J. Radio."},{"issue":"5","key":"10.1016\/j.biopha.2025.118086_bib32","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.21873\/invivo.13308","article-title":"Comparing the influences of metformin and berberine on the intestinal microbiota of rats with nonalcoholic steatohepatitis","volume":"37","author":"Chen","year":"2023","journal-title":"Vivo (Brooklyn)"},{"issue":"4","key":"10.1016\/j.biopha.2025.118086_bib33","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2\u2212\u0394\u0394CT Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"issue":"3","key":"10.1016\/j.biopha.2025.118086_bib34","first-page":"562","article-title":"Challenges and opportunities in NASH drug development","volume":"29","author":"Harrison","year":"2023","journal-title":"Nat. Med. 2023 29:3"},{"issue":"1","key":"10.1016\/j.biopha.2025.118086_bib35","doi-asserted-by":"crossref","first-page":"G42","DOI":"10.1152\/ajpgi.00443.2014","article-title":"The xanthine oxidase inhibitor febuxostat suppresses development of nonalcoholic steatohepatitis in a rodent model","volume":"309","author":"Nakatsu","year":"2015","journal-title":"Am. J. Physiol. -Gastrointest. Liver Physiol."},{"issue":"2","key":"10.1016\/j.biopha.2025.118086_bib36","doi-asserted-by":"crossref","first-page":"80","DOI":"10.4103\/tmj.tmj_15_18","article-title":"Effects of berberine on high-fat\/high-sucrose-induced nonalcoholic steatohepatitis in experimental rats","volume":"47","author":"Eman","year":"2019","journal-title":"Tanta Med. J."},{"issue":"2","key":"10.1016\/j.biopha.2025.118086_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabet.2020.07.010","article-title":"Trimethylamine N-oxide levels are associated with NASH in obese subjects with type 2 diabetes","volume":"47","author":"Le\u00f3n-Mimila","year":"2021","journal-title":"Diabetes Metab."},{"issue":"02","key":"10.1016\/j.biopha.2025.118086_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.24321\/2349.7181.201906","article-title":"Evaluation of Pro-Inflammatory Markers IL-6 and TNF-a and their Correlation with Non-Alcoholic Fatty Liver Disease","volume":"06","author":"Singh","year":"2019","journal-title":"J. Adv. Res. Med."},{"issue":"6","key":"10.1016\/j.biopha.2025.118086_bib39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0066328","article-title":"Serum fucosylated haptoglobin as a novel diagnostic biomarker for predicting hepatocyte ballooning and nonalcoholic steatohepatitis","volume":"8","author":"Kamada","year":"2013","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.biopha.2025.118086_bib40","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/j.cgh.2012.08.012","article-title":"Intestinal permeability and its regulation by zonulin: diagnostic and therapeutic implications","volume":"10","author":"Fasano","year":"2012","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118086_bib41","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41580-019-0177-4","article-title":"The many functions of ESCRTs","volume":"21","author":"Vietri","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"25","key":"10.1016\/j.biopha.2025.118086_bib42","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.3748\/wjg.v24.i25.2661","article-title":"Apoptosis and non-alcoholic fatty liver diseases","volume":"24","author":"Kanda","year":"2018","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.biopha.2025.118086_bib43","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1091\/mbc.e16-12-0855","article-title":"\u201cTumor susceptibility gene 101 regulates predisposition to apoptosis via ESCRT machinery accessory proteins,\u201d","volume":"28","author":"Kaul","year":"2017","journal-title":"Mol. Biol. Cell"},{"issue":"2","key":"10.1016\/j.biopha.2025.118086_bib44","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0016-5085(03)00907-7","article-title":"Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis","volume":"125","author":"Feldstein","year":"2003","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.biopha.2025.118086_bib45","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1038\/emboj.2010.6","article-title":"VHS domains of ESCRT-0 cooperate in high-avidity binding to polyubiquitinated cargo","volume":"29","author":"Ren","year":"2010","journal-title":"EMBO J."},{"key":"10.1016\/j.biopha.2025.118086_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2010\/362847","article-title":"Role of Toll-Like Receptors and Their Downstream Molecules in the Development of Nonalcoholic Fatty Liver Disease","volume":"2010","author":"Miura","year":"2010","journal-title":"Gastroenterol. Res Pr."},{"issue":"2","key":"10.1016\/j.biopha.2025.118086_bib47","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/liv.14311","article-title":"Cellular endo-lysosomal dysfunction in the pathogenesis of non-alcoholic fatty liver disease","volume":"40","author":"Du","year":"2020","journal-title":"Liver Int."},{"issue":"5","key":"10.1016\/j.biopha.2025.118086_bib48","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.7150\/ijbs.69024","article-title":"Hgs deficiency caused restrictive cardiomyopathy via disrupting proteostasis","volume":"18","author":"Li","year":"2022","journal-title":"Int J. Biol. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2025.118086_bib49","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41572-018-0025-4","article-title":"Lysosomal storage diseases","volume":"4","author":"Platt","year":"2018","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.biopha.2025.118086_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.111106","article-title":"Tumor Susceptibility Gene 101 facilitates rapamycin-induced autophagic flux in neuron cells","volume":"134","author":"Cheng","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2025.118086_bib51","doi-asserted-by":"crossref","first-page":"4","DOI":"10.37349\/edd.2022.00002","article-title":"Extracellular vesicles in metabolic dysfunction associated fatty liver disease: mechanisms, diagnostic and therapeutic implications","author":"Wu","year":"2022","journal-title":"Explor. Dig. Dis."},{"issue":"3","key":"10.1016\/j.biopha.2025.118086_bib52","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1007\/s10620-012-2391-1","article-title":"Febuxostat improves the local and remote organ changes induced by intestinal ischemia\/reperfusion in rats","volume":"58","author":"Shafik","year":"2013","journal-title":"Dig. Dis. Sci."},{"issue":"13","key":"10.1016\/j.biopha.2025.118086_bib53","doi-asserted-by":"crossref","DOI":"10.1002\/asia.202300179","article-title":"Synthesis, anti-adipogenic, and insulin-sensitizing potential of benzosuberene-alkyl sulfone (BSAS) analogues","volume":"18","author":"Goel","year":"2023","journal-title":"Chem. Asian J."},{"issue":"1","key":"10.1016\/j.biopha.2025.118086_bib54","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3390\/antiox12010133","article-title":"The xanthine oxidase inhibitor febuxostat suppresses adipogenesis and activates Nrf2","volume":"12","author":"Higa","year":"2023","journal-title":"Antioxidants"},{"issue":"6","key":"10.1016\/j.biopha.2025.118086_bib55","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1159\/000366394","article-title":"Aberrant hepatic MicroRNA expression in nonalcoholic fatty liver disease","volume":"34","author":"Feng","year":"2014","journal-title":"Cell. Physiol. Biochem."},{"issue":"1","key":"10.1016\/j.biopha.2025.118086_bib56","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s12974-021-02181-4","article-title":"miR-1224 contributes to ischemic stroke-mediated natural killer cell dysfunction by targeting Sp1 signaling","volume":"18","author":"Feng","year":"2021","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.biopha.2025.118086_bib57","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.736677","article-title":"Analysis of miRNAs profiles in serum of patients with steatosis and steatohepatitis","volume":"9","author":"Vulf","year":"2021","journal-title":"Front Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118086_bib58","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1365-2567.2010.03374.x","article-title":"Lipopolysaccharide-induced miR-1224 negatively regulates tumour necrosis factor-\u03b1 gene expression by modulating Sp1","volume":"133","author":"Niu","year":"2011","journal-title":"Immunology"},{"key":"10.1016\/j.biopha.2025.118086_bib59","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.neures.2023.04.003","article-title":"miR-6216 regulates neural stem cell proliferation by targeting RAB6B","volume":"194","author":"Li","year":"2023","journal-title":"Neurosci. Res"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222500280X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222500280X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T19:57:05Z","timestamp":1759003025000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S075333222500280X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":59,"alternative-id":["S075333222500280X"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118086","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Febuxostat alleviate metabolic dysfunction-associated steatohepatitis in rat model via targeting inflammation, cell death, and intestinal barrier dysfunction","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118086","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118086"}}